Anders Gabrielsen

5.1k total citations
89 papers, 3.3k citations indexed

About

Anders Gabrielsen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anders Gabrielsen has authored 89 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 21 papers in Molecular Biology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anders Gabrielsen's work include Heart Rate Variability and Autonomic Control (14 papers), Cardiovascular and exercise physiology (13 papers) and Heart Failure Treatment and Management (10 papers). Anders Gabrielsen is often cited by papers focused on Heart Rate Variability and Autonomic Control (14 papers), Cardiovascular and exercise physiology (13 papers) and Heart Failure Treatment and Management (10 papers). Anders Gabrielsen collaborates with scholars based in Sweden, Denmark and United States. Anders Gabrielsen's co-authors include Gabrielle Paulsson‐Berne, Peter Norsk, Göran K. Hansson, Ulf Hedin, Jens Kastrup, Lasse Folkersen, Per Eriksson, Hanna E. Agardh, Bettina Pump and Anne-Louise Hemdahl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Bioinformatics.

In The Last Decade

Anders Gabrielsen

87 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Gabrielsen Sweden	32	1.1k	964	532	528	526	89	3.3k
Vanesa Esteban Spain	30	1.5k 1.4×	1.6k 1.6×	427 0.8×	458 0.9×	480 0.9×	72	4.2k
Praveen Chander United States	36	828 0.8×	1.5k 1.6×	491 0.9×	646 1.2×	444 0.8×	96	4.1k
Erik Øie Norway	34	1.3k 1.2×	1.6k 1.7×	386 0.7×	551 1.0×	449 0.9×	82	4.1k
Wei Feng Shen China	36	1.6k 1.5×	882 0.9×	455 0.9×	923 1.7×	331 0.6×	201	4.1k
Mónica Rupérez Spain	27	1.7k 1.6×	1.4k 1.5×	407 0.8×	408 0.8×	321 0.6×	29	4.0k
Christos Chatziantoniou France	41	1.3k 1.2×	1.4k 1.4×	647 1.2×	510 1.0×	702 1.3×	133	4.2k
Jing Wang China	28	719 0.7×	1.6k 1.7×	924 1.7×	465 0.9×	376 0.7×	265	4.0k
Tadashi Yamakawa Japan	35	718 0.7×	1.3k 1.3×	197 0.4×	542 1.0×	630 1.2×	95	3.9k
Tetsuro Shishido Japan	36	1.8k 1.7×	1.3k 1.3×	335 0.6×	607 1.1×	519 1.0×	149	4.0k
Hideo Izawa Japan	33	2.0k 1.9×	933 1.0×	370 0.7×	1.0k 2.0×	404 0.8×	183	4.0k

Countries citing papers authored by Anders Gabrielsen

Since Specialization

Citations

This map shows the geographic impact of Anders Gabrielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Gabrielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Gabrielsen more than expected).

Fields of papers citing papers by Anders Gabrielsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Gabrielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Gabrielsen. The network helps show where Anders Gabrielsen may publish in the future.

Co-authorship network of co-authors of Anders Gabrielsen

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Gabrielsen. A scholar is included among the top collaborators of Anders Gabrielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Gabrielsen. Anders Gabrielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gallo, Federico, et al.. (2025). Flanking age: Multilingualism and its role in shaping cognitive decline and neural dynamics. NeuroImage. 317. 121312–121312.

Vilahur, Gemma, Monika Aržanauskaitė, Soumaya Ben‐Aicha, et al.. (2024). Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction. European Heart Journal. 45(17). 1553–1567. 6 indexed citations

Egnell, Ann‐Charlotte, Magnus Åstrand, Samuel J. Daniels, et al.. (2024). Safety, Tolerability, and Pharmacodynamics of AZD3366 (Optimized Human CD39L3 Apyrase) Alone and in Combination With Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo‐Controlled Study. Journal of the American Heart Association. 13(11). e033985–e033985. 1 indexed citations

George, Richard T. De, Sami A. Omar, Magnus Åstrand, et al.. (2024). Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First‐in‐Human, Randomized, Single‐Blind, Placebo‐Controlled Study. Journal of the American Heart Association. 13(15). e034067–e034067. 4 indexed citations

Lam, Carolyn S.P., Lars H. Lund, Sanjiv J. Shah, et al.. (2023). Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results. Journal of Cardiac Failure. 30(1). 104–110. 38 indexed citations

Varma, Vijayalakshmi, Dominic Sinibaldi, Emily L. Ongstad, et al.. (2022). Abstract 11971: Identification of Response Biomarkers and Signaling Pathways Associated With the LOX-1 Blockade by MEDI6570 in Type 2 Diabetes. Circulation. 146(Suppl_1). 2 indexed citations

Egnell, Ann‐Charlotte, Magnus Åstrand, Samuel J. Daniels, et al.. (2022). Abstract 13097: Safety, Pharmacokinetics, and Pharmacodynamics of AZD3366 Alone and in Combination With Aspirin and Ticagrelor in Healthy Subjects. Circulation. 146(Suppl_1). 1 indexed citations

Prescott, Eva, Oskar Angerås, David Erlinge, et al.. (2022). Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study. International Journal of Cardiology. 365. 34–40. 8 indexed citations

Verouhis, Dinos, Felix Böhm, Per Eriksson, et al.. (2021). Arginase 1 is upregulated at admission in patients with ST‐elevation myocardial infarction. Journal of Internal Medicine. 290(5). 1061–1070. 9 indexed citations

10.

Prescott, Eva, Oskar Angerås, David Erlinge, et al.. (2021). EFFICACY, SAFETY AND TOLERABILITY OF THE 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR AZD5718 IN PATIENTS WITH RECENT MYOCARDIAL INFARCTION: A PHASE 2A STUDY (FLAVOUR). Journal of the American College of Cardiology. 77(18). 136–136. 1 indexed citations

11.

Silva, Cristina da, Anders Sahlén, Lars Lund, et al.. (2014). Gender differences in myocardial function and arterio-ventricular coupling in response to maximal exercise in adolescent floor-ball players. BMC Sports Science Medicine and Rehabilitation. 6(1). 24–24. 2 indexed citations

12.

Pilbrow, Anna P., Lasse Folkersen, John F. Pearson, et al.. (2012). The Chromosome 9p21.3 Coronary Heart Disease Risk Allele Is Associated with Altered Gene Expression in Normal Heart and Vascular Tissues. PLoS ONE. 7(6). e39574–e39574. 33 indexed citations

13.

Razuvaev, Anton, Johan Ekstrand, Lasse Folkersen, et al.. (2011). Correlations Between Clinical Variables and Gene-expression Profiles in Carotid Plaque Instability. European Journal of Vascular and Endovascular Surgery. 42(6). 722–730. 39 indexed citations

14.

Folkersen, Lasse, Ferdinand van’t Hooft, Ekaterina Chernogubova, et al.. (2010). Association of Genetic Risk Variants With Expression of Proximal Genes Identifies Novel Susceptibility Genes for Cardiovascular Disease. Circulation Cardiovascular Genetics. 3(4). 365–373. 63 indexed citations

15.

Fux, Thomas, Peter Svenarud, Karl‐Henrik Grinnemo, et al.. (2010). Extracorporeal Membrane Oxygenation as a Rescue of Intractable Ventricular Fibrillation and Bridge to Heart Transplantation. European Journal of Heart Failure. 12(3). 301–304. 13 indexed citations

16.

Halle, Martin, Anders Gabrielsen, Gabrielle Paulsson‐Berne, et al.. (2010). Sustained Inflammation Due to Nuclear Factor-Kappa B Activation in Irradiated Human Arteries. Journal of the American College of Cardiology. 55(12). 1227–1236. 150 indexed citations

17.

Díez, Diego, Åsa M. Wheelock, Susumu Goto, et al.. (2009). The use of network analyses for elucidating mechanisms in cardiovascular disease. Molecular BioSystems. 6(2). 289–304. 75 indexed citations

18.

Folkersen, Lasse, Theodosios Kyriakou, Anuj Goel, et al.. (2009). Relationship between CAD Risk Genotype in the Chromosome 9p21 Locus and Gene Expression. Identification of Eight New ANRIL Splice Variants. PLoS ONE. 4(11). e7677–e7677. 132 indexed citations

19.

Gabrielsen, Anders & Peter Norsk. (2007). Effect of spaceflight on the subcutaneous venoarteriolar reflex in the human lower leg. Journal of Applied Physiology. 103(3). 959–962. 11 indexed citations

20.

Qiu, Hong, Anders Gabrielsen, Hanna E. Agardh, et al.. (2006). Expression of 5-lipoxygenase and leukotriene A ₄ hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proceedings of the National Academy of Sciences. 103(21). 8161–8166. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact